RUNX1/CBFβ dosage is critical for MLL leukemias development Meeting Abstract
| Authors: | Yan, X. M.; Hayashi, Y.; Zhao, X. H.; Chen, A. L.; Zhang, Y.; He, F. H.; Dong, Y. Z.; Rao, Y. L.; Li, B.; Conway, R.; Maiques-Diaz, A.; Huang, N. M.; Elf, S. E.; Zuber, J.; Xiao, Z. J.; Tse, W.; Tenen, D. G.; Wang, Q. F.; Chen, W.; Mulloy, J. C.; Nimer, S. D.; Huang, G. |
| Abstract Title: | RUNX1/CBFβ dosage is critical for MLL leukemias development |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243507184 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.2187.2187 |
| Notes: | Meeting Abstract: 2187 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
